MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES
|
|
- Tabitha Flowers
- 5 years ago
- Views:
Transcription
1 MDR AGENTS: RISK FACTORS AND THERAPEUTIC STRATEGIES 1 Marin H. Kollef, MD Professor of Medicine Virginia E. and Sam J. Golman Chair in Respiratory Intensive Care Medicine Washington University School of Medicine St. Louis, Missouri
2 Merck Actavis Arsanis Cubist Cardeas 2 Conflicts of Interest Medimmune Astrazeneca Accelerate Academy for Infection Management Barnes-Jewish Hospital Foundation
3 First Understand your local problem with MDR/XDR! 3
4 Top 3 pathogens causing HAIs: diversity in different countries E. coli (17%) S. aureus (15%) C. difficile (12%) E. coli (18%) Enterococcus (15%) S. aureus (13%) E. coli (27%) S. aureus (14%) Enterococcus (10%) E. coli (15%) Klebsiella (12%) P. aeruginosa (11%) E. coli (17%) Enterococcus (12%) S. aureus (11%) Klebsiella (18%) P. aeruginosa (17%) Acinetobacter (17%) 4 Klebsiella (13%) E. coli (13%) P. aeruginosa (11%) European Centre for Disease Prevention and Control. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals. Stockholm: ECDC; 2013
5 Antibiotic Use Counterintuitive Antibiotic Resistance (MDR/XDR) 5 Inappropriate Therapy
6 Risk Factors for VAP Variable AOR 95% CI P Value OSFI > < Age > Supine* Prior Antibiotics Kollef MH. JAMA 1993;270: *First 24 hours of mechanical ventilation.
7 7 2 Martin-Loeches I, et al. Curr Opin Crit Care 2014; 20:
8 Risk Factors for Resistant Organisms Previous antibiotic treatment Previous hospital admission Nursing home Comorbidities CAD, HIV, COPD, kidney disease Hemodialysis Home wound care (past 30 days) Family member with resistant organism Herrero FS, 8 et al. Semin Respir Crit Care Med. 2012;33;
9 Criteria for Health Care Associated Pneumonia 9 Wunderink RG, et al. N Engl J Med 2014;370:
10 HCAP Criteria Hospitalized in the previous 90 days Nursing home resident Home infusion therapy Chronic dialysis or home wound care Family member with resistant bacteria St. Louis, Missouri Hospitalized in the previous 90 days Criteria Nursing home resident Chronic dialysis ICU admission Milan, Italy Comorbid conditions (CVA, DM, COPD) Criteria Antibiotics in prior 90 days Immunosuppression/Chronic renal failure Home wound care or infusion therapy Nursing home resident Hospitalized in prior 90 days Joint Japanese- ICU admission U.S. Criteria Immunosuppression Hospitalized in prior 90 days Antibiotics in prior 6 months Poor functional status 10 Vazquez-Guillamet C, Kollef MH. ICM (In press). A risk factor approach for MDR syndromes (pneumonia)
11 Nagoya, Japan Hospitalized in prior 90 days Criteria Immunosuppression Antibiotics in prior 90 days Gastric acid suppression medication Tube feeding Nonambulatory status Rome, Italy Criteria One risk factor for HCAP Bilateral infiltrates Pleural effusion pao2/ FiO2 ratio <300 Spanish Criteria Hospitalization in previous 90 days HCAP Residence in a nursing home or extended care facility Home infusion of antibiotics Chronic hemodialysis Home wound care Family member colonized with MDR isolate Spanish Criteria ICP 11 Vazquez-Guillamet C, Kollef MH. ICM (In press). A risk factor approach for MDR syndromes (pneumonia) HIV Organ transplant Chemotherapy, steroids, other immunosuppressive therapy for at least four weeks prior to the diagnosis of pneumonia
12 ATS/IDSA. (2005) AJRCCM 171: Shorr AF, et al. (2012) Clin Infect Dis 54: Aliberti S, et al. (2012) Clin Infect Dis 54: Maruyama T, et al. (2013) Clin Infect Dis 57: Shindo Y, et al. (2013) AJRCCM 188: Falcone M, et al. (2015) PLoS One. 10(4):e Vallés J, et al. (2014) Intensive Care Med 40(4):
13 HCAP Requires Broad Spectrum Empiric Therapy Agent 1 + Agent 2 + Agent 3 13 ATS/IDSA. Am J Resp Crit Care Med. 2005;171:388.
14 MDR Risk Factors in Pneumonia Coming From the Community Logit in 170 patients with pathogen isolated Variable OR 95% CI P Value Prior Hospitalization Nursing Home Aliberti S, et al. Clin Infect Dis 2012; 54:
15 Variable Score *CVA, DM, COPD, antibiotics in preceeding 90 days, home wound care, home infusion therapy Aliberti S, et 15 al. Clin Infect Dis 2012; 54: None 0 Co-morbidites* 0.5 Nursing home 3 Prior hospitalization 4 Chronic renal failure 5
16 Validation of Risk Score for MDR in Pneumonia From the Community Variable Score Recent hospitalization 4 Nursing home 3 Chronic renal failure 2 ICU admission 1 HCAP Definition Risk Score > 0 Sens Spec PPV NPV Accuracy 91.0% 34.3% 54.8% 81.3% 60.7% 88.6% 54.5% 63.0% 84.5% 70.4% 16 Shorr AF, et al. Clin Infect Dis 2012; 54:
17 % of Patients Validation of Risk Score for MDR in Pneumonia From the Community Prevalence of Resistant Pathogens as Function of Score Figure 1. Receiver Operating Curve Figure p< n=456 n= n= Total Score 17 Shorr AF, et al. Clin Infect Dis 2012; 54: N = 977 Resistant pathogen = 456 (46.7%)
18 Proposed Algorithm for HCAP Therapy HCAP Is Present (from a nursing home, home infusion therapy, home wound care, dialysis center, hospitalized in past 90 days) Assess Severity of Illness (ICU or mechanical ventilation) and MDR Risks (recent antibiotic therapy, poor functional status, recent hospitalization, immune supression) Severe Illness NO YES 0 1 MDR Risks: Treat for common CAP pathogens (consider oral Rx) Quinolone, β-lactam/macrolide 18 > 2 MDR Risks: Consider hospital admit Treat for MDR pathogens with HAP recommendations 0 MDR Risks: Consider IV therapy with β-lactam PLUS Macrolide or Quinolone Brito V, Niederman MS. Current Opinion in Infectious Diseases 2009; 22: > 1 MDR Risks: Treat for MDR pathogens with HAP recommendations Need 3 drugs
19 Thirty-day mortality in CAP and HCAP, with each HCAP stratified by the number of (MDR) risk factors 19 Maruyama T et al. Clin Infect Dis. 2013;57:
20 Comparison of Clinical Prediction Models for Resistant Bacteria in CAP ROC AUC was similar for each of the six algorithms, ranging from 0.63 to Self WH, et al. Acad Emerg Med 2015;22:
21 Local Prevalence of MDR/XDR is Key! 21 Martin-Loeches I, et al. Curr Opin Crit Care 2014; 20:
22 Clinical Features Suggesting Community- Acquired MRSA Pneumonia 22 Wunderink RG, et al. N Engl J Med 2014;370:
23 In the Critically ill Patient Hit Hard and Fast 23
24 Probability of Adequate Empiric Therapy in Patients with K. pneumoniae Bacteremia 24 Girometti, et al. Medicine 2014;93:
25 BJH/WU St. Louis 1250-Beds (+ 350 beds): Medical ICU 44 beds Surgical/Trauma ICU 24 beds Neuro ICU - 24 beds Coronary Care Unit - 18 beds Cardiothoracic ICU - 24 beds 25 PACU 80 beds Specialty Surgery ICU 12 beds LVAD/ECMO ICU 9 beds LTAC 12 beds New Wing 24 beds 271 ICU Beds
26 26 Vazquez-Grande G, et al. Semin Respir Crit Care Med Feb;36(1):
27 Combination Therapy Gram-negative Bacteremia Complicated by Severe Sepsis (N = 760) Pathogen, N (%) Community Acquired N = 72 Healthcare-associated Community onset N = 269 Hospital - onset N = 419 P. aeruginosa (n = 132) 6 (4.5) 44 (33.3) 82 (62.1) Acinetobacter sp. (n = 63) 3 (4.8) 16 (25.4) 44 (69.8) Other NFGNR (n = 32) 0 (0) 2 (6.3) 30 (93.7) E. coli (n = 232) 43 (18.5) 102 (44.0) 87 (37.5) Klebsiella sp. (n = 188) 10 (5.3) 61 (32.4) 117 (62.2) Enterobacter sp. (n = 76) 5 (6.5) 24 (31.6) 47 (61.8) Other enterobacteriaceae (n = 98) 10 (10.2) 43 (43.9) 45 (45.9) 27 Micek ST, et al. AAC 2010;54:1742.
28 Sepsis Due to GNB in the Hospital Setting 28 Micek ST, et al. AAC 2010;54:
29 Antimicrobial Resistance 29 Micek ST, et al. AAC 2010;54:1742.
30 Resistance (%) The Impact of Combination Therapy: Hospital-Onset or Healthcare-Associated Alone Plus Ciprofloxacin Plus Gentamicin Cefepime Imipenem or Meropenem Piperacillintazobactam 30 Micek ST, et al. AAC 2010;54:1742.
31 De-Escalation and Outcome In Severe Sepsis/Septic Shock N = Garnacho-Montero J, et al. Intensive Care Med 2014;40:32-40.
32 New Paradigm - Pathogen directed therapies have arrived! 32
33 Empiric Gram-Negative Regimen Recommendation + MRSA + MRSA 33 UptoDate 2015
34 Conclusions Understand your local epidemiology Appropriate drug selection and Adequate dosing/duration/infusion/timing Use microbiology results to de-escalate Insure compliance w/ ASP Employ new agents/technology as available 34
35 35 Thank you!
Sepsis Treatment: Early Identification Remains the Key Issue
Sepsis Treatment: Early Identification Remains the Key Issue Marin H. Kollef, MD Professor of Medicine Washington University School of Medicine Director, Medical Critical Care Director, Respiratory Care
More informationCare Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline DRAFT for review cycle 08/02/17 CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: All MHS employed providers within Primary Care, Urgent Care, and In-Hospital Care. The secondary audience
More informationCARE OF THE ADULT PNEUMONIA PATIENT
Care Guideline CARE OF THE ADULT PNEUMONIA PATIENT Target Audience: The target audience for this Care Guideline is all MultiCare providers and staff, including those associated with our clinically integrated
More informationCommunity Acquired & Nosocomial Pneumonias
Community Acquired & Nosocomial Pneumonias IDSA/ATS 2007 & 2016 Guidelines José Luis González, MD Clinical Assistant Professor of Medicine Outline Intro - Definitions & Diagnosing CAP treatment VAP & HAP
More informationBrice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine
Brice Taylor Assistant Professor Division of Pulmonary and Critical Care Medicine Discuss advances in predicting prognosis Understand dwhat we know (and don t know) about the Microbiology Recognize important
More informationGuess or get it right?
Guess or get it right? Antimicrobial prescribing in the 21 st century Robert Masterton Traditional Treatment Paradigm Conservative start with workhorse antibiotics Reserve more potent drugs for non-responders
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY
HEALTHCARE-ASSOCIATED PNEUMONIA: EPIDEMIOLOGY, MICROBIOLOGY & PATHOPHYSIOLOGY David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health
More informationClinical characteristics of health care-associated pneumonia in a Korean teaching hospital
Respiratory Medicine (2010) 104, 1729e1735 available at www.sciencedirect.com journal homepage: www.elsevier.com/locate/rmed Clinical characteristics of health care-associated pneumonia in a Korean teaching
More informationCAP, HCAP, HAP, VAP. 1. In 1898, William Osler described community-acquired pneumonia as:
1. In 1898, William Osler described community-acquired pneumonia as: Brad Sharpe, M.D. Professor of Clinical Medicine Department of Medicine UCSF sharpeb@medicine.ucsf.edu I have no relevant financial
More informationSepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment
Sepsis new definitions of sepsis and septic shock and Novelities in sepsis treatment What is sepsis? Life-threatening organ dysfunction caused by a dysregulated host response to infection A 1991 consensus
More informationGuidelines for Pneumonia
Guidelines for Pneumonia Michael S. Niederman, MD Professor of Medicine Vice-Chairman, Department of Medicine State University of New York at Stony Brook Chairman, Department of Medicine Winthrop-University
More informationPneumonia Community-Acquired Healthcare-Associated
Pneumonia Community-Acquired Healthcare-Associated Edwin Yu Clin Infect Dis 2007;44(S2):27-72 Am J Respir Crit Care Med 2005; 171:388-416 IDSA / ATS Guidelines Microbiology Principles and Practice of Infectious
More informationHEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION
HEALTHCARE-ASSOCIATED PNEUMONIA: DIAGNOSIS, TREATMENT & PREVENTION David Jay Weber, M.D., M.P.H. Professor of Medicine, Pediatrics, & Epidemiology Associate Chief Medical Officer, UNC Health Care Medical
More informationContinuous Infusion of Antibiotics In The ICU: What Is Proven? Professor of Medicine Vice-Chairman, Department of Medicine SUNY at Stony Brook
Continuous Infusion of Antibiotics In The ICU: What Is Proven? Michael S. Niederman, M.D. Chairman, Department of Medicine Winthrop-University Hospital Mineola, NY Professor of Medicine Vice-Chairman,
More informationVAP in COPD patients. Ignacio Martin-Loeches. St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland.
VAP in COPD patients Ignacio Martin-Loeches St James s University Hospital. Trinity Centre for Health Sciences. Dublin Ireland. Outline Pathophysiology Is enough information? COPD trends in ICU How do
More informationA Snapshot of Colistin Use in South-East Europe and Particularly in Greece
A Snapshot of Colistin Use in South-East Europe and Particularly in Greece Helen Giamarellou 02.05.2013 When Greek Physicians Prescribe Colistin? It is mainly prescribed in the ICU for VAP, bacteremia
More informationOptimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches
Optimizing Antibiotic Therapy in the ICU For Pneumonia Current and Future Approaches Andrew F. Shorr, MD, MPH Washington Hospital Center Georgetown Univ. Disclosures I have served as a consultant to, researcher/investigator
More informationClinical Practice Guidelines for Nursing- and Healthcareassociated Pneumonia (NHCAP) [Complete translation] $
respiratory investigation 51 (2013) 103 126 Contents lists available at SciVerse ScienceDirect Respiratory Investigation journal homepage: www.elsevier.com/locate/resinv Guideline Clinical Practice Guidelines
More informationClinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia
ORIGINAL ARTICLE Clinical Characteristics of Nursing and Healthcare-Associated Pneumonia: A Japanese Variant of Healthcare-Associated Pneumonia Tadashi Ishida, Hiromasa Tachibana, Akihiro Ito, Hiroshige
More informationDecember 3, 2015 Severe Sepsis and Septic Shock Antibiotic Guide
Severe Sepsis and Septic Shock Antibiotic Guide Surviving Sepsis: The choice of empirical antimicrobial therapy depends on complex issues related to the patient s history, including drug intolerances,
More informationPneumonia Severity Scores:
Pneumonia Severity Scores: Are they Accurate Predictors of Mortality? JILL McEWEN, MD FRCPC Clinical Professor Department of Emergency Medicine University of British Columbia Vancouver, BC Canada President,
More informationSevere β-lactam allergy. Alternative (use for mild-moderate β-lactam allergy) therapy
Recommended Empirical Antibiotic Regimens for MICU Patients Notes: The antibiotic regimens shown are general guidelines and should not replace clinical judgment. Always assess for antibiotic allergies.
More informationAbstract. Introduction
ORIGINAL ARTICLE INFECTIOUS DISEASES Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care
More informationPotential Conflicts of Interests
Potential Conflicts of Interests Research Grants Agency for Healthcare Research and Quality Akers Bioscience, Inc. Pfizer, Inc. Scientific Advisory Boards Pfizer, Inc. Cadence Pharmaceuticals Kimberly
More informationHospital-acquired Pneumonia
Hospital-acquired Pneumonia Hospital-acquired pneumonia (HAP) Pneumonia that occurs at least 2 days after hospital admission. The second most common and the leading cause of death due to hospital-acquired
More informationGuidelines 2017 for the management of hospitalacquired pneumonia (HAP) and. ventilator-associated. pneumonia (VAP)
Guidelines 2017 for the management of hospitalacquired pneumonia (HAP) and ventilator-associated Modifiez le style des sous-titres du masque pneumonia (VAP) Filip Moerman Présentation pour les soins int
More informationTreatment of febrile neutropenia in patients with neoplasia
Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece
More informationDilemmas in Septic Shock
Dilemmas in Septic Shock William Janssen, M.D. Assistant Professor of Medicine National Jewish Health University of Colorado Denver Health Sciences Center A 62 year-old female presents to the ED with fever,
More informationHealth Care Associated Pneumonia (HCAP): A Critical Appraisal to Improve Identification, Management, and Outcomes Proceedings of the HCAP Summit
SUPPLEMENT ARTICLE Health Care Associated Pneumonia (HCAP): A Critical Appraisal to Improve Identification, Management, and Outcomes Proceedings of the HCAP Summit Marin H. Kollef, 1 Lee E. Morrow, 3 Robert
More informationThink Globally: Strategies to Improve the Culture of Antibiotic Prescribing
Think Globally: Strategies to Improve the Culture of Antibiotic Prescribing October 11, 2017 Paul Lewis, PharmD, BCPS (AQ-ID) Johnson City Medical Center Johnson City, TN 1 Outline Introduction to stewardship
More informationGuidelines. 14 Nov Marc Bonten
Guidelines 14 Nov 2014 Marc Bonten Treatment of Community-Acquired Pneumonia SWAB/ NVALT guideline 2011, replaced SWAB guideline 2005 Empirical treatment must cover the most likely causative pathogen.
More informationKatherine E. Kollef; Richard M. Reichley, RPh; Scott T. Micek, PharmD; and Marin H. Kollef, MD, FCCP
CHEST Original Research The Modified Score Outperforms Curb65 Pneumonia Severity Score as a Predictor of 30-Day Mortality in Patients With Methicillin- Resistant Staphylococcus aureus Pneumonia* Katherine
More informationEpidemiology of Infectious Complications of H1N1 Influenza Virus Infection
Epidemiology of Infectious Complications of H1N1 Influenza Virus Infection Lyn Finelli, DrPH, MS Lead, Influenza Surveillance and Outbreak Response Epidemiology and Prevention Branch Influenza Division
More informationTo develop guidelines for the use of appropriate antibiotics for adult patients with CAP and guidance on IV to PO conversion.
Page 1 of 5 TITLE: COMMUNITY-ACQUIRED PNEUMONIA (CAP) EMPIRIC MANAGEMENT OF ADULT PATIENTS AND IV TO PO CONVERSION GUIDELINES: These guidelines serve to aid clinicians in the diagnostic work-up, assessment
More informationHealthcare-associated infections acquired in intensive care units
SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit
More informationOnline Supplement for:
Online Supplement for: INFLUENCE OF COMBINED INTRAVENOUS AND TOPICAL ANTIBIOTIC PROPHYLAXIS ON THE INCIDENCE OF INFECTIONS, ORGAN DYSFUNCTIONS, AND MORTALITY IN CRITICALLY ILL SURGICAL PATIENTS A PROSPECTIVE,
More informationCURRENT GUIDELINES FOR SEPSIS MANAGEMENT
HELLENIC SEPSIS STUDY GROUP www.sepsis.gr CURRENT GUIDELINES FOR SEPSIS MANAGEMENT Evangelos J. Giamarellos-Bourboulis, MD, PhD Associate Professor of Medicine 4 th Department of Internal Medicine, National
More informationEducational Workshop
Educational Workshop EW02: Management of severe sepsis and septic shock anno 2015 Arranged with ESGBIS & International Sepsis Forum (ISF) Convenors: W. Joost Wiersinga, Amsterdam, NL Tom van der Poll,
More informationThe IDSA/ATS consensus guidelines on the management of CAP in adults
The IDSA/ATS consensus guidelines on the management of CAP in adults F. Piffer F. Tardini R. Cosentini U.O. Medicina d'urgenza, Gruppo NIV, Fondazione Ospedale Maggiore Policlinico, Mangiagalli e Regina
More informationANWICU knowledge
ANWICU knowledge www.anwicu.org.uk This presenta=on is provided by ANWICU We are a collabora=ve associa=on of ICUs in the North West of England. Permission to provide this presenta=on has been granted
More informationPneumonia Update Overview" Community-Acquired Pneumonia" Management of the Hospitalized Patient. Care of the Hospitalized Patient"
Pneumonia Update 2010 Management of the Hospitalized Patient Scott A. Flanders, M.D." Professor of Medicine" Director, Hospitalist Program" University of Michigan" Overview" Community Acquired Pneumonia
More informationUPDATE IN HOSPITAL MEDICINE
UPDATE IN HOSPITAL MEDICINE FLORIDA CHAPTER ACP MEETING 2016 Himangi Kaushal, M.D., F.A.C.P. Program Director Memorial Healthcare System Internal Medicine Residency DISCLOSURES None OBJECTIVES Review some
More informationUrinary Tract Infections in Hospitalized Patients
Urinary Tract Infections in Hospitalized Patients Puerto Rico Chapter Annual Meeting Daniel C. DeSimone, MD March 9, 2019 2017 MFMER slide-1 Disclosures for speaker: Date of presentation: 3/9/2019 No relevant
More informationMICHIGAN MEDICINE GUIDELINES FOR TREATMENT OF URINARY TRACT INFECTIONS IN ADULTS
When to Order a Urine Culture: Asymptomatic bacteriuria is often treated unnecessarily, and accounts for a substantial burden of unnecessary antimicrobial use. National guidelines recommend against testing
More informationPREVENTION AND TREATMENT OF BACTERIAL INFECTIONS IN CIRRHOSIS
PREVENTION AND TREATMENT OF BACTERIAL INFECTIONS IN CIRRHOSIS Dr. J. Fernández. Head of the Liver Unit Hospital Clinic Barcelona, Spain AEEH Postgraduate Course, Madrid, February 15 2017 Prevalence of
More informationOriginal Article Mahidol Univ J Pharm Sci 2015; 42 (4), MT. Nguyen 1, TD. Dang Nguyen 1* 1
Original Article Mahidol Univ J Pharm Sci 2015; 42 (4), 195-202 Investigation on hospital-acquired pneumonia and the association between hospital-acquired pneumonia and chronic comorbidity at the Department
More informationInfections In Cirrhotic patients. Dr Abid Suddle Institute of Liver Studies King s College Hospital
Infections In Cirrhotic patients Dr Abid Suddle Institute of Liver Studies King s College Hospital Infection in cirrhotic patients Leading cause morbidity/mortality Common: 30-40% of hospitalised cirrhotic
More informationPharmacologyonline 1: (2010) ewsletter Singh and Kochbar. Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of
Optimizing Pharmacokinetic/Pharmacodynamics Principles & Role of Cefoperazone Sulbactam Singh M*, Kochhar P* Medical & Research Division, Pfizer India. Summary Antimicrobial resistance is associated with
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for
More informationFrequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia
Frequency of Occurrence and Antimicrobial Susceptibility of Bacteria from ICU Patients with Pneumonia Helio S. Sader, M.D.* Mariana Castanheira, Ph.D. Rodrigo E. Mendes, Ph.D. Robert K. Flamm, Ph.D. JMI
More informationNosocomial Pneumonia. <5 Days: Non-Multidrug-Resistant Bacteria
Nosocomial Pneumonia Meredith Deutscher, MD Troy Schaffernocker, MD Ohio State University Burden of Hospital-Acquired Pneumonia Second most common nosocomial infection in the U.S. 5-10 episodes per 1000
More informationPneumonia Update Overview. Community-Acquired Pneumonia. Management of the Hospitalized Patient. Care of the Hospitalized Patient
Pneumonia Update 2010 Management of the Hospitalized Patient Scott A. Flanders, M.D. Professor of Medicine Director, Hospitalist Program University of Michigan Overview Community Acquired Pneumonia (CAP)
More informationLa farmacologia in aiuto
Ferrara, 15 giugno 2018 La farmacologia in aiuto Pier Giorgio Cojutti, Federico Pea Istituto di Farmacologia Clinica Azienda Sanitaria Universitaria Integrata di Udine Therapeutic Drug Monitoring of Beta-Lactams
More informationHospital Acquired Pneumonias
Hospital Acquired Pneumonias Hospital Acquired Pneumonia ( HAP ) Hospital acquired pneumonia ( HAP ) is defined as an infection of the lung parenchyma developing during hospitalization and not present
More informationWork up of Respiratory & Wound Cultures:
Work up of Respiratory & Wound Cultures: Culture work up 2 Systematic approaches 1 Work up of Respiratory & Wound Cultures Resident flora Colonizing organisms Pathogens 2 Work up of Respiratory & Wound
More informationInfectious Disease in the Critically Ill Patient
Infectious Disease in the Critically Ill Patient Heather L. Evans, MD MS FACS Director of Surgical Infectious Disease Harborview Medical Center Asst. Professor UW Department of Surgery New Antibiotics:
More informationImpact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia
Journal of Antimicrobial Chemotherapy Advance Access published May 17, 2011 J Antimicrob Chemother doi:10.1093/jac/dkr176 Impact of guideline-consistent therapy on outcome of patients with healthcare-associated
More informationInadequate Empiric Antibiotic Therapy among Canadian. Hospitalized Solid-Organ Transplant Patients: Incidence and Impact on Hospital Mortality
Inadequate Empiric Antibiotic Therapy among Canadian Hospitalized Solid-Organ Transplant Patients: Incidence and Impact on Hospital Mortality by Bassem Hamandi A thesis submitted in conformity with the
More informationSupplementary Online Content
Supplementary Online Content Lee JS, Nsa W, Hausmann LRM, et al. Quality of care for elderly patients hospitalized for pneumonia in the United States, 2006 to 2010. JAMA Intern Med. Published online September
More informationUsefulness of Procalcitonin in the management of Infections in ICU. P Damas CHU Sart Tilman Liège
Usefulness of Procalcitonin in the management of Infections in ICU P Damas CHU Sart Tilman Liège Procalcitonin Peptide 116 AA Produced by parenchymal cells during «sepsis»: IL1, TNF, IL6 : stimulators
More informationAntibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005)
Antibiotic Resistance Pattern of Blood and CSF Culture Isolates At NHLS Academic Laboratories (2005) Streptococcus pneumoniae (SP) Blood Culture Isolates Penicillin intermediate Penicillin Cefotaxime 336
More informationRisk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia
Wang and Wang BMC Infectious Diseases (2016) 16:377 DOI 10.1186/s12879-016-1701-1 RESEARCH ARTICLE Open Access Risk factors to predict drug-resistant pathogens in hemodialysis-associated pneumonia Ping-huai
More informationWORKSHOP. The Multiple Facets of CAP. Community acquired pneumonia (CAP) continues. Jennifer s Situation
Practical Pointers pointers For for Your your Practice practice The Multiple Facets of CAP Dr. George Fox, MD, MSc, FRCPC, FCCP Community acquired pneumonia (CAP) continues to be a significant health burden
More informationDifference of health-care associated pneumonia between large hospitals and small hospitals in Japan
67 ORIGINAL Difference of health-care associated pneumonia between large hospitals and small hospitals in Japan Masanari Watanabe 1,2, Kazuhiro Kato 3, Kenichi Takeda 4, Tatsuya Konishi 5, Jun Kurai 1,6,
More informationVAP Prevention bundles
VAP Prevention bundles Dr. Shafiq A.Alimad MD Head of medical department at USTH YICID workshop, 15-12-2014 Care Bundles What are they & why use them? What are Care Bundles? Types of Care Bundles available
More informationLimiting the Attributable Mortality of. Healthcare-Associated Infection & Multidrug Resistance. in Critically Ill Patients
Sigma Theta Tau International 26 th International Nursing Research Congress San Juan, Puerto Rico, 23-27 July 2015 Limiting the Attributable Mortality of Healthcare-Associated Infection & Multidrug Resistance
More informationThe Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure An Underappreciated Issue
[ Original Research ] The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure An Underappreciated Issue Andrew F. Shorr, MD, MPH; Kristen Fisher, MD; Scott T. Micek, PharmD; and Marin
More informationBC Sepsis Network Emergency Department Sepsis Guidelines
The provincial Sepsis Clinical Expert Group developed the BC, taking into account the most up-to-date literature (references below) and expert opinion. For more information about the guidelines, and to
More informationSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Mitchell M. Levy MD, MCCM Professor of Medicine Chief, Division of Pulmonary, Sleep, and Critical Care
More informationEpidemiology and Etiology of Community-Acquired Pneumonia 761 Lionel A. Mandell
LOWER RESPIRATORY TRACT INFECTIONS Preface Thomas M. File, Jr xiii Community-Acquired Pneumonia: Pathophysiology and Host Factors with Focus on Possible New Approaches to Management of Lower Respiratory
More informationExpert rules. for Gram-negatives
Academic Perspective in Expert rules Emerging Issues of Resistance in Gram-ve Bacteria for Gram-negatives Trevor Winstanley Sheffield Teaching Hospitals Presented on behalf of David Livermore University
More informationSeverity assessment of healthcareassociated pneumonia and pneumonia in immunosuppression
Eur Respir J 212; 4: 121 121 DOI: 1.1183/931936.187811 CopyrightßERS 212 Severity assessment of healthcareassociated pneumonia and pneumonia in immunosuppression Maria Carrabba*,#, Marina Zarantonello*,
More informationInvasive Pulmonary Aspergillosis in
Infection & Sepsis Symposium Porto, April 1-3, 2009 Invasive Pulmonary Aspergillosis in Non-Immunocompromised Patients Stijn BLOT, PhD General Internal Medicine & Infectious Diseases Ghent University Hospital,
More informationCarbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you?
Carbapenem-resistant Enterobacteriaceae (CRE): Coming to a hospital near you? Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust www.reflectionsipc.com @jonotter Contents What s the problem?
More informationMichael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center
CA-MRSA Pneumonia Michael S. Niederman, M.D. Clinical Director Pulmonary and Critical Care Medicine New York Presbyterian Hospital Weill Cornell Medical Center Professor of Clinical Medicine Weill Cornell
More informationCommunity Acquired Pneumonia: Measures to Improve Management and Healthcare Quality
Community Acquired Pneumonia: Measures to Improve Management and Healthcare Quality Gonzalo Bearman MD, MPH Assistant Professor of Internal Medicine Divisions of Quality Health Care & Infectious Diseases
More informationGUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known
More informationPULMONARY EMERGENCIES
EMERGENCIES I. Pneumonia A. Bacterial Pneumonia (most common cause of a focal infiltrate) 1. Epidemiology a. Accounts for up to 10% of hospital admissions in the U.S. b. Most pneumonias are the result
More informationby author Epidemiology of infections in the ICU
Epidemiology of infections in the ICU Anastasia Antoniadou Internal Medicine Infectious Diseases Assistant Professor Athens University Medical School University General Hospital ATTIKON Epidemiology of
More informationChapter 22. Pulmonary Infections
Chapter 22 Pulmonary Infections Objectives State the incidence of pneumonia in the United States and its economic impact. Discuss the current classification scheme for pneumonia and be able to define hospital-acquired
More informationImportance of Functional Assessment in the Management of Community-acquired and Healthcare-associated Pneumonia
ORIGINAL ARTICLE Importance of Functional Assessment in the Management of Community-acquired and Healthcare-associated Pneumonia Kosuke Kosai 1,2, Koichi Izumikawa 2,3, Yoshifumi Imamura 3, Hironori Tanaka
More informationP. aeruginosa: Present therapeutic options in Intensive Care. Y. Van Laethem (CHU St-Pierre & Université libre de Bruxelles, Brussels, Belgium)
P. aeruginosa: Present therapeutic options in Intensive Care Y. Van Laethem (CHU St-Pierre & Université libre de Bruxelles, Brussels, Belgium) Activity vs Pseudomonas aeruginosa Pseudomonas aeruginosa
More informationCommunity Acquired Pneumonia. Background & Rationale to North American Guidelines. Lionel Mandell MD FRCPC Brussels Belgium
Community Acquired Pneumonia Background & Rationale to North American Guidelines Lionel Mandell MD FRCPC Brussels Belgium Consider Impact of the disease Issues to reflect upon Impact of the Disease 3-4
More informationOutline. Pharmacists Improving Outcomes in the Management of. of Infectious Diseases. Threats Against Desired Outcomes 7/11/2010
Pharmacists Improving Outcomes in the Management of Infectious Diseases Christine Teng, MSc(Clin Pharm) BCPS Assistant Professor Dept of Pharmacy, National University of Singapore Principal Pharmacist
More informationImportance of kinetics of procalcitonin in septic patients. János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery
Importance of kinetics of procalcitonin in septic patients János Fazakas MD, PhD Semmelweis University, Department of Transplantation and Surgery Host pathogen interactions the innate and the adaptive
More informationCommunity-Acquired Pneumonia OBSOLETE 2
Community-Acquired Pneumonia OBSOLETE 2 Clinical practice guidelines serve as an educational reference, and do not supersede the clinical judgment of the treating physician with respect to appropriate
More informationORIGINAL INVESTIGATION. Health Care Associated Pneumonia Requiring Hospital Admission. Epidemiology, Antibiotic Therapy, and Clinical Outcomes
ORIGINAL INVESTIGATION Health Care Associated Pneumonia Requiring Hospital Admission Epidemiology, Antibiotic Therapy, and Clinical Outcomes Jordi Carratalà, MD, PhD; Analía Mykietiuk, MD; Núria Fernández-Sabé,
More informationA risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia
Shorr et al. BMC Infectious Diseases 2013, 13:268 RESEARCH ARTICLE Open Access A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia
More informationAugmented Renal Clearance: Let s Get the Discussion Flowing
Augmented Renal Clearance: Let s Get the Discussion Flowing Terry Makhoul, PharmD PGY-2 Emergency Medicine Pharmacy Resident University of Rochester Medical Center Strong Memorial Hospital Disclosures
More informationKey words: community acquired; epidemiology; health care; mechanical ventilation; mortality; nosocomial; outcomes; pneumonia; resource use
Epidemiology and Outcomes of Health-care Associated Pneumonia* Results From a Large US Database of Culture-Positive Pneumonia Marin H. Kollef, MD, FCCP; Andrew Shorr, MD, MPH, FCCP; Ying P. Tabak, PhD;
More informationPneumococcal pneumonia
Pneumococcal pneumonia Wei Shen Lim Consultant Respiratory Physician & Honorary Professor of Medicine Nottingham University Hospitals NHS Trust University of Nottingham Declarations of interest Unrestricted
More informationTRANSPARENCY COMMITTEE. Opinion. 07 January 2009
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 07 January 2009 500 mg, powder for solution for perfusion B/10 bottles (CIP: 387 355-6) Applicant: JANSSEN-CILAG doripenem
More informationEun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D.
Eun-Young Kang, M.D., Jae Wook Lee, M.D., Ji Yung Choo, M.D., Hwan Seok Yong, M.D., Ki Yeol Lee, M.D., Yu-Whan Oh, M.D. Department of Radiology, Korea University Guro Hospital, College of Medicine, Korea
More informationPHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS
PHARMACOKINETIC & PHARMACODYNAMIC OF ANTIBIOTICS SITI HIR HURAIZAH MD TAHIR Bpharm (UKM), MSc (Clinical Microbiology) (UoN) CLINICAL PHARMACIST HOSPITAL MELAKA WHY STUDY PHARMACOKINETICS (PK) AND PHARMACODYNAMICS
More informationSeverity assessment of healthcare-associated pneumonia. and pneumonia in immunosuppression
ERJ Express. Published on March 9, 2012 as doi: 10.1183/09031936.00187811 Severity assessment of healthcare-associated pneumonia and pneumonia in immunosuppression Maria Carrabba *, #, Marina Zarantonello
More informationSepsis: What Is It Really?
Sepsis: What Is It Really? Steven D. Burdette, MD, FIDSA, FACP Professor of Medicine Wright State University Boonshoft School of Medicine Director of Antimicrobial Stewardship for Premier Health and Miami
More informationESCMID Online Lecture Library. by author
Novel PK/PD data on the optimisation of colistin and the carbapenems Diamantis Plachouras Athens, Greece Hot Topics on Infections in the Critically Ill Patient, ESCMID Postgraduate Education Course, 31
More informationFrom the labo to the ICU: Surveillance cultures in daily ICU practice. Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital
From the labo to the ICU: Surveillance cultures in daily ICU practice Pieter Depuydt MD PhD Dept. Intensive Care Ghent University Hospital Question 1: What is the current practice of surveillance cultures
More informationSpeed is Life but a Sledgehammer Helps Too: Combination Antibiotic Therapy For Septic Shock
Speed is Life but a Sledgehammer Helps Too: Combination Antibiotic Therapy For Septic Shock Anand Kumar MD, FRCPC, FCCP, FCCM Associate Professor of Medicine University of Manitoba Health Sciences Centre
More informationClostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate
Clostridium Difficile Infection: Applying New Treatment Guidelines and Strategies to Reduce Recurrence Rate Objectives Summarize the changing epidemiology and demographics of patients at risk for Clostridium
More information